Simone Jueliger

A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

Amit M. Oza, Ursula A. Matulonis, Angeles Alvarez Secord et al. · Clinical Cancer Research · 2019 · 86 citations · Full text

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

Simone Jueliger, John F. Lyons, Sara Cannito et al. · Epigenetics · 2016 · 80 citations · Full text

Chemoprevention Strategy, Cancer Biology, Anti-cancer Agent +18

A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses

Daniela Matei, Sharad Ghamande, Lynda D. Roman et al. · Clinical Cancer Research · 2018 · 61 citations · Full text

First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos et al. · Clinical Cancer Research · 2020 · 61 citations · Full text

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Marie Sébert, Aline Renneville, Cécile Bally et al. · Haematologica · 2019 · 47 citations · Full text